Your browser doesn't support javascript.
loading
Prostate cancer: net survival and cause-specific survival rates after multiple imputation.
Morisot, Adeline; Bessaoud, Faïza; Landais, Paul; Rébillard, Xavier; Trétarre, Brigitte; Daurès, Jean-Pierre.
Afiliação
  • Morisot A; University of Montpellier, Laboratory of Biostatistics, Epidemiology and Public Health (EA2415), 641, avenue du doyen Gaston Giraud, Montpellier Cedex 5, 34093, France. adeline.morisot@gmail.com.
  • Bessaoud F; Hérault Cancer Registry, 208, rue des Apothicaires, Montpellier Cedex 5, 34298, France.
  • Landais P; University of Montpellier, Laboratory of Biostatistics, Epidemiology and Public Health (EA2415), 641, avenue du doyen Gaston Giraud, Montpellier Cedex 5, 34093, France.
  • Rébillard X; Department of Urology - BeauSoleil Clinic, 119 avenue de Lodève, Montpellier, 34070, France.
  • Trétarre B; Hérault Cancer Registry, 208, rue des Apothicaires, Montpellier Cedex 5, 34298, France.
  • Daurès JP; University of Montpellier, Laboratory of Biostatistics, Epidemiology and Public Health (EA2415), 641, avenue du doyen Gaston Giraud, Montpellier Cedex 5, 34093, France.
BMC Med Res Methodol ; 15: 54, 2015 Jul 28.
Article em En | MEDLINE | ID: mdl-26216355
ABSTRACT

BACKGROUND:

Estimations of survival rates are diverse and the choice of the appropriate method depends on the context. Given the increasing interest in multiple imputation methods, we explored the interest of a multiple imputation approach in the estimation of cause-specific survival, when a subset of causes of death was observed.

METHODS:

By using European Randomized Study of Screening for Prostate Cancer (ERSPC), 20 multiply imputed datasets were created and analyzed with a Multivariate Imputation by Chained Equation (MICE) algorithm. Then, cause-specific survival was estimated on each dataset with two

methods:

Kaplan-Meier and competing risks. The two pooled cause-specific survival and confidence intervals were obtained using Rubin's rules after complementary log-log transformation. Net survival was estimated using Pohar-Perme's estimator and was compared to pooled cause-specific survival. Finally, a sensitivity analysis was performed to test the robustness of our constructed multiple imputation model.

RESULTS:

Cause-specific survival performed better than net survival, since this latter exceeded 100 % for almost the first 2 years of follow-up and after 9 years whereas the cause-specific survival decreased slowly and than stabilized at around 94 % at 9 years. Sensibility study results were satisfactory.

CONCLUSIONS:

On our basis of prostate cancer data, the results obtained by cause-specific survival after multiple imputation appeared to be better and more realistic than those obtained using net survival.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Animals / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Animals / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article